Personal information

Oncology, Single cell Analysis, Traditional Chinese Medicine
Hong Kong SAR China

Activities

Employment (2)

China-Japan Friendship Hospital: Beijing, CN

2018-09-01 to 2021-06-30 | resident doctor
Employment
Source: Self-asserted source
Shuyue Zheng

China-Japan Friendship Hospital: Beijing, Beijing, CN

2017-07-01 to 2018-06-15 | intern doctor
Employment
Source: Self-asserted source
Shuyue Zheng

Education and qualifications (2)

University of Hong Kong: Hong Kong, Hong Kong, CN

2021-09-01 to present | PhD student (Clinical Oncology)
Education
Source: Self-asserted source
Shuyue Zheng

Beijing University of Chinese Medicine: Beijing, Beijing, CN

2013-09-01 to 2021-06-30 | bachelor, postgraduate (8-year Excellent Bachelor and Master Joint Medical Programme)
Education
Source: Self-asserted source
Shuyue Zheng

Professional activities (10)

European Society for Medical Oncology: Madrid, ES

2023-05-04 to present
Membership
Source: Self-asserted source
Shuyue Zheng

American Association For Cancer Research: Orlando, US

2022-10-17 to present
Membership
Source: Self-asserted source
Shuyue Zheng

University of Hong Kong: Hong Kong, HK

2024-02-27 | Wong Ching Yee Medical Postgraduate Scholarship 2023/2024 (Li Ka Shing Faculty of Medicine)
Distinction
Source: Self-asserted source
Shuyue Zheng

The University of Hong Kong: Hong Kong, HK

2023-03 | YS and Christabel Lung Postgraduate Scholarship 2022/2023 (Li Ka Shing Faculty of Medicine )
Distinction
Source: Self-asserted source
Shuyue Zheng

The University of Hong Kong: Hong Kong, HK

2021-06 | Postgraduate Scholarship
Distinction
Source: Self-asserted source
Shuyue Zheng

Chinese Government Scholarship: Beijing, CN

2020-10 | National Scholarship
Distinction
Source: Self-asserted source
Shuyue Zheng

Chinese Government Scholarship: Beijing, CN

2019-10 | National Scholarship
Distinction
Source: Self-asserted source
Shuyue Zheng

Beijing University of Chinese Medicine: Beijing, CN

2017-12 | Top Ten University Students
Distinction
Source: Self-asserted source
Shuyue Zheng

Beijing University of Chinese Medicine: Beijing, CN

2016 | University-Level Special Outstanding Scholarship
Distinction
Source: Self-asserted source
Shuyue Zheng

China Scholarship Council: Beijing, CN

2015-05-17 | Exchange Award (Exchange Biomedicine Program in Nanyang Technological University)
Distinction
Source: Self-asserted source
Shuyue Zheng

Works (11)

Ferroptosis: Promising approach for cancer and cancer immunotherapy

Cancer Letters
2023-05 | Journal article
Contributors: Shuyue Zheng; Xin-Yuan Guan
Source: check_circle
Crossref

The Role of Tumor Microenvironment in Invasion and Metastasis of Esophageal Squamous Cell Carcinoma

Frontiers in Oncology
2022-06-22 | Journal article
Part of ISSN: 2234-943X
Contributors: Shuyue Zheng; Beilei Liu; Xinyuan Guan
Source: Self-asserted source
Shuyue Zheng

Association Between Efficacy of Immune Checkpoint Inhibitors and Sex: An Updated Meta-Analysis on 21 Trials and 12,675 Non-Small Cell Lung Cancer Patients

Frontiers in Oncology
2021-08-26 | Journal article
Part of ISSN: 2234-943X
Contributors: Chongxiang Xue; Shuyue Zheng; Huijing Dong; Xingyu Lu; Xu Zhang; Jingyi Zhang; Jia Li; Huijuan Cui
Source: Self-asserted source
Shuyue Zheng

Recurrence of Immune-Related Adverse Events After Immune Checkpoint Inhibitor Rechallenge

JAMA Oncology
2020-11-01 | Journal article
Part of ISSN: 2374-2437
Contributors: Shu-Yue Zheng; Hua Duan; Hui-Juan Cui
Source: Self-asserted source
Shuyue Zheng

Cryoablation for advanced non-small cell lung cancer: a protocol for a systematic review

BMJ Open
2020-09 | Journal article
Contributors: Hua Duan; Shu-Yue Zheng; Chufan Luo; Xueni Fang; Dan Wang; Haoyue Pang; Man Wang; Yu Chen; Tian Zhou; Quanwang Li et al.
Source: check_circle
Crossref

Construction and Validation of an Autophagy-related Prognostic Model for Survival Predicting in Colon Cancer Patients

2020-08-12 | Other
Contributors: Shu-Yue Zheng; Faying Chen; Hui-Juan Cui
Source: check_circle
Crossref

Body mass index: Another way to predict the efficacy of immune checkpoint inhibitors?

International Immunopharmacology
2020-07 | Journal article
Part of ISSN: 1567-5769
Contributors: Shu-Yue Zheng; Hui-Juan Cui
Source: Self-asserted source
Shuyue Zheng

The efficacy and safety of immune checkpoint inhibitors in non-small cell lung cancer patients of different age groups: a meta-analysis

Clinical and Translational Oncology
2020-07-20 | Journal article
Contributors: S.-Y. Zheng; H.-J. Cui; H. Duan; Y.-M. Peng; Q. Li; C.-Y. Sun; J.-Y. Zhang; W. Shen; X. Zhang; K. Tan et al.
Source: check_circle
Crossref

Efficacy of PD-1/PD-L1 inhibitors in the treatment of non-small cell lung cancer patients with sensitive genes mutation

ANNALS OF ONCOLOGY
2019-10-03 | Conference abstract
Source: Self-asserted source
Shuyue Zheng

Treatment of severe rash caused by crizotinib with both traditional Chinese medicine and Western medicine

Medicine
2018-11 | Journal article
Part of ISSN: 0025-7974
Part of ISSN: 1536-5964
Contributors: Shu-Yue Zheng; Wen Shen; Yan-Mei Peng; Hui-Juan Cui; Hua Duan; Yu-Qin Qiu; Qiang Li; Jing-Yi Zhang; Chen-Yao Sun; Xu Zhang
Source: Self-asserted source
Shuyue Zheng

Research Progress of Traditional Chinese Medicine in Treating Liver-Fire Type Insomnia

Medical Recapitulate
2017-07-01 | Journal article
Source: Self-asserted source
Shuyue Zheng